| Display title | Chemistry:Cefuroxime axetil |
| Default sort key | Cefuroxime axetil |
| Page length (in bytes) | 8,818 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 810334 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>Unex |
| Date of page creation | 20:11, 5 February 2024 |
| Latest editor | imported>Unex |
| Date of latest edit | 20:11, 5 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Cefuroxime axetil, sold under the brand name Ceftin among others, is a second generation oral cephalosporin antibiotic.
It is an acetoxyethyl ester prodrug of cefuroxime which is effective orally. The activity depends on in vivo hydrolysis and release of cefuroxime tablets.
It was patented in 1976 and... |
